Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinyu Guo
Observed names:
Guo, Xinyu,
Xinyu GUO
Institution:
Tianjin Medical University General Hospital
Observed institutions:
Tianjin Medical University General Hospital,
Institute of Hematology & Blood Diseases Hospital,
Tianjin Medical University
ORCID:
0000-0002-5503-6663
Observed ORCID:
0000-0002-5503-6663
OpenAlex ID:
A5067766975
TIM3 / CEACAM1 pathway involves in myeloid‐derived suppressor cells induced CD8 + T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome
2022
·
Shunjie Yu
, Xiaotong Ren
, et al.
·
Immunology
·
46
Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
2022
·
Lijuan Li
, Shunjie Yu
, et al.
·
Clinical and Experimental Medicine
·
9
PDF
VISTA in hematological malignancies: a review of the literature
2024
·
Yuanjia Duan
, Xiaotong Ren
, et al.
·
Frontiers in Immunology
·
6
PDF
Advances in the study of TIM3 in myelodysplastic syndrome
2025
·
Xinyu Guo
, Shunjie Yu
, et al.
·
Frontiers in Immunology
·
4
PDF
Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
2023
·
Xinyu Guo
, Shunjie Yu
, et al.
·
Heliyon
·
4
The difference of double-positive T cells and double-negative-T cells in myeloid neoplasms before and after chemotherapy, and after COVID-19 infection
2024
·
Xinyu Guo
, Xiaotong Ren
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
9
Citation count:
70
H-index:
4
I10-index:
1
Year
Topic
Type